Navigation Links
US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results

between visits is

complementary to our evidence-based clinical pathways that have been

adopted by approximately 90 percent of practices affiliated under

comprehensive service agreements and form the foundation of an

integrated Care Management model.

-- We added 190 physicians to our network and, in January 2008, executed

a comprehensive services agreement with a 47 physician practice that

represents our largest practice affiliation.

-- The Company continued to match affiliated practices with economic

models that both align our economic interests and acknowledge the

varied scope of services that our customers seek. During the fourth

quarter, two practices previously affiliated under comprehensive

agreements chose to affiliate under our OPS model.

-- We ended the year with over 600 providers implemented on our

electronic medical record, an increase of over 70% since

December 31, 2006.

-- From the end of 2006, our accounts receivable days outstanding

decreased by 5 days to 33 days as of December 31, 2007.

-- We strengthened our management team through the addition of Glen

Laschober as chief operating officer and through the expansion of our

regional leadership team to enhance the support of our existing

practice operations and the integration of new practices into our


Results of Operations

The Company operates and manages its business through four operating segments. The table below compares the results of the fourth quarter of 2007 and fiscal year 2007, to the results of the corresponding period of the prior year and the preceding quarter (in millions).

Q4 Q4 % Q3 % Fiscal Fiscal %

2007 2006 Change 2007 Change 2007 2006 Change



SOURCE US Oncology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
3. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
5. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
6. PRA International to Present Audioconference on Oncology Research - Nov. 8
7. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
8. AG Mednet to Provide Image Network for Southwest Oncology Group
9. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
10. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
11. Oncology Metrics and Cureline Announce Joint Marketing Agreement
Post Your Comments:
(Date:9/15/2014)... 15, 2014   Global Science & Technology, ... products and services for satellite and weather systems, ... Integrated Services (OASIS) from the General Services Administration ... to provide the government best-value solutions for complex ... category in Pool 4. The OASIS SB award ...
(Date:9/15/2014)... 2014 Cancer Immunotherapy Market ... T-cell Therapies is a new market research report ... three principal types of therapeutics that have become ... cancer immunotherapy (which is often called "immuno-oncology") in ... Adoptive cellular immunotherapy. , The regular use ...
(Date:9/15/2014)... 15, 2014 EnGeneIC, Ltd. , ... treatment of cancer through the targeted delivery of ... together with the Asbestos Disease Research Institute (ADRI), ... South Wales (NSW) Premier,s Award for Excellence in ... the hospitals that will be involved in the ...
(Date:9/15/2014)... 2014  FlexTech Alliance today issued a dual-focused ... demonstrators (demos) and a functional electronic print leaflet.  ... due on October 22, 2014 and full proposals ... selected are provided by the US Army Research ... by the proposing organization. Photo - ...
Breaking Biology Technology:Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 2EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 3FlexTech Alliance Issues 2015 Request for Proposals in Flexible, Printed Electronics 2
... privately held,medical device firm, announced that it has successfully ... Crux IVC Filter. The filter, used to,prevent an often ... Center by David Rosenthal, Chief of Vascular Surgery. Every,year ... PE and,between 120,000 - 150,000 die as a result. ...
... Influenza ... Testing, ... company developing rapid molecular diagnostics and detection,systems, announces a EUR3 million ... The award will fund the,development and validation of a fully automated, ...
... More Than Doubles Assets Under Management, UTRECHT, The ... European venture capital firm, today announced,the closing of its ... II (GHC II). The new fund, which is Gilde,s ... raised to invest in European,healthcare opportunities. GHC II was ...
Cached Biology Technology:Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter 2Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections 2Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund 2
(Date:9/15/2014)... and gut microbes influence processes from digestion to disease ... most biodiverse terrestrial ecosystems on the planet, more is ... the tropics. Smithsonian scientists and colleagues working on Panama,s ... a single tree were home to more than 400 ... tree species contained more than 7,000 different kinds. , ...
(Date:9/15/2014)... 2014) The so-called central dogma of molecular ... provided a simplified explanation for how genetic information ... , In reality, of course, the process is ... nearly 60 years ago by Nobel Laureate Francis ... one, there are multiple types of RNA, three ...
(Date:9/15/2014)... populations may continue to drop in French Guiana, despite ... National de la Chasse et de la Faune Sauvage ... data retrieved from camera traps in the Nouragues National ... data to current harvest rates in the region., "In ... Guiana," said Matthias Tobler, a scientist with the San ...
Breaking Biology News(10 mins):Smithsonian scientists discover tropical tree microbiome in Panama 2Scientists discover RNA modifications in some unexpected places 2
... growing asthma rates among children with exposure to ... study in the May issue of Journal ... Levels in North Carolina Schools: Comparison of Integrated ... using integrated pest management (IPM) to control cockroaches ...
... has implicated machinery that maintains the flow of potassium in ... Expression of a previously unknown form of a key such ... normal in the brain memory hub of people with the ... variation. An extensive series of experiments suggest that ...
... May 5, 2009 Researchers at the Hebrew University ... the tumor-risk factor in utilizing human embryonic stem cells. ... the promising field of stem cell therapy. ... to all cells of the mature human body (and ...
Cached Biology News:Flow of potassium into cells implicated in schizophrenia 2Flow of potassium into cells implicated in schizophrenia 3Hebrew University researchers neutralize tumor growth in embryonic stem cell therapy 2
Mouse monoclonal [BC-4] to Aggrecan xxPEN ( Abpromise for all tested applications). entrezGeneID: 176 SwissProtID: P16112...
... molecular screening, low melting point agarose where ... is recommended for separation of nucleic acids ... PCR products. Micro ABgarose is also suited ... for blotting techniques. At a 3% concentration, ...
Rabbit polyclonal to Nck alpha ( Abpromise for all tested applications). entrezGeneID: 4690 SwissProtID: P16333...
Sheep polyclonal to Salmonella Thomasville ( Abpromise for all tested applications). Antigen: Native Salmonella thomasville...
Biology Products: